Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Summary

This phase II trial studies the side effects and how well imetelstat sodium works in treating younger patients with relapsed or refractory solid tumors. Imetelstat sodium may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2014-06-30

Primary completion

2016-03-25

Completion

—

Drugs

Indications